Dr. Driesens Ans
ActiveDr. Driesens Ans has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €334k and a net result of €84k. Equity is growing by ~21.7% per year across the filed fiscal years. Its solvency ranks better than 68% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
95
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability94▼-4
Solvency100=
Growth52=
Track record94
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity ample (current ratio 4.78 against 9.24 in 2024; short-term debt: 20.6% and cash: 94.1% of total assets), and 20.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
79.4%
Return on assets
19.9%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-06-2026, 50 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
50 d early
2024
31 d early
2023
7 d early
2022
27 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€334k▲ 0.2%
2024 · €333k
2022: €173k
2023: €245k
2024: €333k
2022 → 2025
Total assets
€420k▲ 12.5%
2024 · €374k
2022: €249k
2023: €282k
2024: €374k
2022 → 2025
Net result
€84k▼ 5.1%
2024 · €88k
2022: €168k
2023: €72k
2024: €88k
2022 → 2025
Working capital
€327k▼ 0.3%
2024 · €328k
2022: €169k
2023: €242k
2024: €328k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€173k-€245k▲ 41.5%€333k▲ 35.9%€334k▲ 0.2%
Operating result€242k-€100k▼ 58.6%€121k▲ 20.8%€102k▼ 16.0%
Net result€168k-€72k▼ 57.3%€88k▲ 22.6%€84k▼ 5.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 16% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €420k
Fixed assets
€6k▲ 14.5%
Current assets
€414k▲ 12.4%
Equity and liabilities €420k
Equity
€334k▲ 0.2%
Debt
€87k▲ 113%
The debt ratio rises from 10.9% to 20.6%. Equity and debt are higher.
Key figures and ratios
EBITDA
€104k▼
2024 · €122k
Cash flow
€86k▼
2024 · €89k
Solvency
79.4%▼
2024 · 89.1%
Current ratio
4.78▼
2024 · 9.24
Quick ratio
4.78▼
2024 · 9.24
Debt / equity
0.26▲
2024 · 0.12
ROE
25.0%▼
2024 · 26.4%
ROA
19.9%▼
2024 · 23.6%
Interest coverage
284.54▼
2024 · 903.06
Debt
€87k▲
2024 · €41k
Debt ≤ 1 year
€87k▲
2024 · €40k
Income taxes
€22k▼
2024 · €36k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€374k€420k▲
Fixed assets21/28€5k€6k▲
Tangible fixed assets22/27€5k€6k▲
Plant, machinery and equipment23€3k€3k▼
Furniture and vehicles24€2k€4k▲
Current assets29/58€368k€414k▲
Amounts receivable within one year40/41€30k€18k▼
Trade receivables40€28k€9k▼
Other amounts receivable41€3k€9k▲
Current investments50/53€300k€0▼
Cash at bank and in hand54/58€38k€396k▲
Deferred charges and accrued income490/1€529€551▲
Equity and liabilities
Total equity and liabilities10/49€374k€420k▲
Equity10/15€333k€334k▲
Contributions10/11€5k€5k=
Reserves13€328k€329k▲
Distributable reserves133€328k€329k▲
Profit (loss) carried forward14-€0
Amounts payable17/49€41k€87k▲
Amounts payable within one year42/48€40k€87k▲
Trade debts44€1k€63▼
Suppliers440/4€1k€63▼
Taxes, remuneration and social security45€37k€2k▼
Taxes450/3€37k€2k▼
Other amounts payable47/48€2k€84k▲
Accrued charges and deferred income492/3€756€0▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€2k▲
Other operating charges640/8€1k€1k▲
Gross operating margin9900€123k€105k▼
Operating profit (loss)9901€121k€102k▼
Financial income75/76B€3k€5k▲
Recurring financial income75€3k€5k▲
Financial charges65/66B€135€364▲
Recurring financial charges65€135€364▲
Profit (loss) for the period before taxes9903€124k€106k▼
Income taxes67/77€36k€22k▼
Profit (loss) for the period9904€88k€84k▼
Profit (loss) for the period to be appropriated9905€88k€84k▼
Appropriation of the result
Profit (loss) to be appropriated9906€88k€84k▼
Transfer to equity691/2€88k€538▼
To other reserves6921€88k€538▼
Profit to be distributed694/7-€83k
Return on contributions (dividend)694-€83k
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
11-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
24-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Weakest financial yearnet €72k ▼57.3%
Net result drops to €72k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity doublescurrent ratio 7.58
Current ratio from 3.24 to 7.58; short-term debt falls from €76k to €37k.
31-12
Financial
Equity above €200kEq €245k ▲41.5%
2 profitable years in a row build equity to €245k.
04-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Tielt · 1 establishment unit since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Kasteelstraat 328700 TieltGround area
3,506 m²
Building footprint
503 m²
Volume, LiDAR
1,600 m³
2 parcels, Flanders · tallest building 8.7 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Felix D'Hoopstraat 181, 8700 Tielt
since 20212.318.581.595
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 37303I0582/00H003 | Flanders | 2,426 m² | 1 · 232 m² | - |
| 37302F0052/00K000 | Flanders | 1,080 m² | 1 · 270 m² | 8.7 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
GUNAYDIN ZEHRA
BE 1001.982.878
Verviers · Eq €334k
DR MUKENDI MUDIMBIYI MURIEL,MEDECINE GENERALE
BE 0810.306.722
Brussel · Eq €333k
Bureau Médical Orl Goret
BE 0460.413.072
Huy · Eq €334k
Maison de Santé Triangle
BE 0732.992.475
Anderlecht · Eq €334k
CMMED
BE 0669.787.176
Court-Saint-Etienne · Eq €333k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,172 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded01-06-2021
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
86909Human health activities
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.